The 1st Oncobell symposium on “Mechanisms of cancer and new therapeutic strategies” officially introduces the IDIBELL cancer research program at a European level
Oncobell organises its first symposium Read More »
From Reus to Puertollano – 665 kilometres – in 29 and a half hours. This is the result of an epic challenge fulfilled by José María Moya, a relative of a multiple sclerosis (MS) patient. This anonymous citizen decided to undertake a cycling challenge last September 7 and 8 to raise funds for the research
Cycling for multiple sclerosis Read More »
An article published in The Lancet Respiratory Medicine by Dr. Manel Esteller, Director of the Epigenetics and Cancer Biology Program (PEBC) of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Researcher and Professor of Genetics at the University of Barcelona, proves that a specific pattern of epigenetic alterations in lung cancer predictss whether the tumor will
A new epigenetic signature predicts the response to immunotherapy in lung cancer Read More »
The study has been based on cutting-edge phosphoproteic techniques, and has been carried out thanks to a grant granted by the La Marató de TV3 Foundation
People who have their evening meal before 9 pm or wait at least two hours before going to sleep have a 20% lower risk of breast and prostate cancer
Early Supper Associated With Breast and Prostate Cancer Risk Read More »
The IDIBELL colorectal cancer research team, led by Dr. Vïctor Moreno, has contributed to a large-scale study that led to the description of 11 new genetic variants associated with this type of cancer. This study, published in in the Journal of the National Cancer Institute, provides insight into the architecture of common genetic variation contributing
Novel Common Genetic Susceptibility Loci for Colorectal Cancer Read More »
The best-known way our cells and tissues store biological information is their genetic code, derived from the DNA sequence (Deoxyribonucleic Acid). During the last two decades, the epigenetic code has been identified as capable of controlling our DNA through a series of chemical tags. Today, an article published in Cell by Manel Esteller, coordinator of
The Third Warehouse of Biological Information: The RNA Code Read More »
Hereditary Colorectal Cancer. Genetic Basis and Clinical Implications Researchers of the Hereditary Cancer Program of the Catalan Institute of Oncology, IDIBELL (Oncobell), Dr. Laura Valle and Dr. Gabriel Capellá, together with Dr. Stephen B. Gruber of the Norris Comprehensive Cancer Center (University of Southern California), have published a book on hereditary colorectal cancer entitled “Hereditary
New books by IDIBELL authors: hereditary colorectal cancer & stem cell genetics Read More »
Under the coordination of the University of Turin in Italy, members of the EurOPDX Consortium and additional key European academic and SME partners recently secured 5 million € from the European Union’s Horizon 2020 research and innovation programme to build an infrastructure for access to patient-derived cancer xenograft (PDX) models and related data, for academic
On June 21st, the training session “How to support researchers in writing competitive proposals for Horizon 2020” was held at the Duran i Reynals hospital. The course, part of the ICABELL project, was taught by Dr. Sean McCarthy, expert in European funding for research projects. The session, which had a high degree of attendance,
Specialised training session for H2020 project managers Read More »
